Show simple item record

dc.contributor.authorKing, Nen
dc.contributor.authorDieberg, Gen
dc.contributor.authorSmart, NAen
dc.date.accessioned2018-03-20T11:15:23Z
dc.date.available2018-03-20T11:15:23Z
dc.date.issued2016-05-01en
dc.identifier.urihttp://hdl.handle.net/10026.1/11115
dc.description.abstract

© 2016 The Authors. Published by Elsevier B.V. Background Trials of remote ischemic pre-conditioning (RIPC) have suggested this intervention reduces complications of angioplasty and coronary artery by-pass grafting (CABG). The aim of this work was to conduct a systematic review and meta-analysis of the effects of RIPC on mortality and myocardial damage in patients undertaking coronary artery bypass grafting with/without valve surgery. Methods A systematic review and subsequent meta-analysis of randomized controlled trials of RIPC versus usual care or sham RIPC was performed. Results Eighteen studies, totalling 4551 participants were analysed. RIPC reduced post troponin release as indicated by area under the curve at 72 h (μg·L- 1) Mean Difference (MD) - 3.72 (95% CI - 3.92 to - 3.53, p < 0.00001). However there was no significant difference between RIPC and control when mortality odds ratio (OR) 1.27 (95% CI 0.87 to 1.86, p = 0.22); the incidence of new onset atrial fibrillation OR 0.82 (95% CI 0.67 to 1.01, p = 0.06); inotropic support OR 1.27 (95% CI 0.84 to 1.91, p = 0.25); intensive care unit stay in days MD - 0.02 (95% CI - 0.12 to 0.07, p = 0.61); Hospital stay in days MD 0.18 (95% CI - 0.30 to 0.66, p = 0.47) and serum creatinine MD - 0.00 (95% CI - 0.07 to 0.07, p = 0.97) were compared. Conclusions RIPC reduces does not confer any clinical benefit in patients undertaking CABG with/without valve surgery.

en
dc.format.extent1 - 8en
dc.language.isoenen
dc.titleRemote ischaemic pre-conditioning does not affect clinical outcomes following coronary Artery bypass grafting. A systematic review and meta-analysisen
dc.typeJournal Article
plymouth.volume17en
plymouth.publication-statusPublisheden
plymouth.journalClinical Trials and Regulatory Science in Cardiologyen
dc.identifier.doi10.1016/j.ctrsc.2016.03.001en
plymouth.organisational-group/Plymouth
plymouth.organisational-group/Plymouth/00 Groups by role
plymouth.organisational-group/Plymouth/00 Groups by role/Academics
plymouth.organisational-group/Plymouth/Faculty of Medicine and Dentistry
plymouth.organisational-group/Plymouth/Faculty of Medicine and Dentistry/School of Biomedical Sciences
dc.identifier.eissn2405-5875en
dc.rights.embargoperiodNot knownen
rioxxterms.versionofrecord10.1016/j.ctrsc.2016.03.001en
rioxxterms.licenseref.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/en
rioxxterms.typeJournal Article/Reviewen


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record


All items in PEARL are protected by copyright law.
Author manuscripts deposited to comply with open access mandates are made available in accordance with publisher policies. Please cite only the published version using the details provided on the item record or document. In the absence of an open licence (e.g. Creative Commons), permissions for further reuse of content should be sought from the publisher or author.
Theme by 
@mire NV